Complementary AIDS therapies: the good, the bad and the ugly

Area of Science:

• Integrative Medicine
• Public Health
• HIV/AIDS Research

Background:

• Complementary medicine (CM) use is prevalent among individuals with HIV/AIDS.
• Systematic review assessing published data on CM use in this population.
• Data extraction focused on prevalence, effectiveness, risks, and costs.

Discussion:

• Perceived benefits by users contrast with a lack of specific evidence for treatment efficacy.
• While generally viewed as safe, documented risks associated with CM use exist.
• High costs and potential financial exploitation of patients are significant concerns.

Key Insights:

• Prevalence of CM use in HIV/AIDS patients ranges widely from 27% to 100%.
• No definitive data support the specific effectiveness of complementary therapies for HIV/AIDS.
• Evidence suggests potential risks and significant financial burdens associated with CM use.

Outlook:

• Further research is crucial to understand the true benefits and harms of CM in HIV/AIDS care.
• Need for studies evaluating the safety and efficacy profiles of commonly used complementary therapies.
• Investigating patient experiences and economic implications of CM use is essential.